These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 27501763)
1. Metabolism and excretion of 1-hydroxymethylpyrene, the proximate metabolite of the carcinogen 1-methylpyrene, in rats. Bendadani C; Steinhauser L; Albert K; Glatt H; Monien BH Toxicology; 2016 Jul; 366-367():43-52. PubMed ID: 27501763 [TBL] [Abstract][Full Text] [Related]
2. Probenecid, an inhibitor of transmembrane organic anion transporters, alters tissue distribution of DNA adducts in 1-hydroxymethylpyrene-treated rats. Monien BH; Müller C; Bakhiya N; Donath C; Frank H; Seidel A; Glatt H Toxicology; 2009 Jul; 262(1):80-5. PubMed ID: 19481134 [TBL] [Abstract][Full Text] [Related]
3. Effects of Nereis diversicolor on the transformation of 1-methylpyrene and pyrene: transformation efficiency and identification of phase I and II products. Malmquist LM; Christensen JH; Selck H Environ Sci Technol; 2013 May; 47(10):5383-92. PubMed ID: 23611659 [TBL] [Abstract][Full Text] [Related]
4. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
5. The carcinogen 1-methylpyrene forms benzylic DNA adducts in mouse and rat tissues in vivo via a reactive sulphuric acid ester. Bendadani C; Meinl W; Monien BH; Dobbernack G; Glatt H Arch Toxicol; 2014 Mar; 88(3):815-21. PubMed ID: 24337722 [TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of 9-hydroxymethyl-10-methylanthracene and 1-hydroxymethylpyrene to electrophilic, mutagenic and tumorigenic sulfuric acid esters by rat hepatic sulfotransferase activity. Surh YJ; Blomquist JC; Liem A; Miller JA Carcinogenesis; 1990 Sep; 11(9):1451-60. PubMed ID: 2205404 [TBL] [Abstract][Full Text] [Related]
7. Time course of hepatic 1-methylpyrene DNA adducts in rats determined by isotope dilution LC-MS/MS and 32P-postlabeling. Monien BH; Müller C; Engst W; Frank H; Seidel A; Glatt H Chem Res Toxicol; 2008 Oct; 21(10):2017-25. PubMed ID: 18788758 [TBL] [Abstract][Full Text] [Related]
8. Correlation between biomarkers of polycyclic aromatic hydrocarbon exposure and electrophilic tissue burden in a rat model. Tzekova A; Thuot R; Viau C Arch Toxicol; 2004 Jun; 78(6):351-61. PubMed ID: 14749914 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo metabolism of the carcinogen 4-nitropyrene. Upadhyaya P; Von Tungeln LS; Fu PP; el-Bayoumy K Chem Res Toxicol; 1994; 7(5):690-5. PubMed ID: 7841349 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous analysis of naphthols, phenanthrols, and 1-hydroxypyrene in urine as biomarkers of polycyclic aromatic hydrocarbon exposure: intraindividual variance in the urinary metabolite excretion profiles caused by intervention with beta-naphthoflavone induction in the rat. Elovaara E; Väänänen V; Mikkola J Arch Toxicol; 2003 Apr; 77(4):183-93. PubMed ID: 12698233 [TBL] [Abstract][Full Text] [Related]
11. Metabolism and DNA binding of 2-nitropyrene in the rat. Upadhyaya P; Roy AK; Fu PP; el-Bayoumy K Cancer Res; 1992 Mar; 52(5):1176-81. PubMed ID: 1737377 [TBL] [Abstract][Full Text] [Related]
12. Impact of p53 function on the sulfotransferase-mediated bioactivation of the alkylated polycyclic aromatic hydrocarbon 1-hydroxymethylpyrene in vitro. Wohak LE; Monien B; Phillips DH; Arlt VM Environ Mol Mutagen; 2019 Oct; 60(8):752-758. PubMed ID: 31102418 [TBL] [Abstract][Full Text] [Related]
13. Excretion and metabolism of 1-nitropyrene in rats after oral or intraperitoneal administration. Dutcher JS; Sun JD; Bechtold WE; Unkefer CJ Fundam Appl Toxicol; 1985 Apr; 5(2):287-96. PubMed ID: 3987999 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of 1-nitro[14C]pyrene in vivo in the rat and mutagenicity of urinary metabolites. Ball LM; Kohan MJ; Inmon JP; Claxton LD; Lewtas J Carcinogenesis; 1984 Dec; 5(12):1557-64. PubMed ID: 6499108 [TBL] [Abstract][Full Text] [Related]
15. Determination of sulfotransferase forms involved in the metabolic activation of the genotoxicant 1-hydroxymethylpyrene using bacterially expressed enzymes and genetically modified mouse models. Bendadani C; Meinl W; Monien B; Dobbernack G; Florian S; Engst W; Nolden T; Himmelbauer H; Glatt H Chem Res Toxicol; 2014 Jun; 27(6):1060-9. PubMed ID: 24802129 [TBL] [Abstract][Full Text] [Related]
16. Efficient oxidation of promutagenic hydroxymethylpyrenes by cDNA-expressed human alcohol dehydrogenase ADH2 and its inhibition by various agents. Kollock R; Meinl W; Schneider H; Batke M; Frank H; Seidel A; Glatt H Biochem Pharmacol; 2008 Jan; 75(2):527-37. PubMed ID: 17920042 [TBL] [Abstract][Full Text] [Related]
17. Biotransformation of medetomidine in the rat. Salonen JS; Eloranta M Xenobiotica; 1990 May; 20(5):471-80. PubMed ID: 2349806 [TBL] [Abstract][Full Text] [Related]
18. The effects of copollutants on the metabolism and DNA binding of carcinogens. Howard PC; Beland FA Res Rep Health Eff Inst; 1994 May; (66):1-17; discussion 19-25. PubMed ID: 7521645 [TBL] [Abstract][Full Text] [Related]
19. Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers. Paulson SK; Hribar JD; Liu NW; Hajdu E; Bible RH; Piergies A; Karim A Drug Metab Dispos; 2000 Mar; 28(3):308-14. PubMed ID: 10681375 [TBL] [Abstract][Full Text] [Related]
20. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites. Prakash C; Cui D Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]